Veraxa Biotech is trading 11.02% up now at $1.21, in line with supportive biotech-sector sentiment.
- No company-specific headline was reported for October 9, and available market coverage lists no headlines for the stock that day.
- Two biotech IPOs began trading October 9, amid reports of renewed investor appetite for biotech offerings.
- The company’s October 7 update on FDA-aligned research models predates the move and is not a confirmed October 9 catalyst.